메뉴 건너뛰기




Volumn 116, Issue 5, 2009, Pages 1016-1017

Bevacizumab Tachyphylaxis

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

EID: 65349118184     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.01.029     Document Type: Letter
Times cited : (4)

References (3)
  • 1
    • 56549111386 scopus 로고    scopus 로고
    • Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration?
    • Schaal S., Kaplan H.J., and Tezel T.H. Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration?. Ophthalmology 115 (2008) 2199-2205
    • (2008) Ophthalmology , vol.115 , pp. 2199-2205
    • Schaal, S.1    Kaplan, H.J.2    Tezel, T.H.3
  • 2
    • 34848817406 scopus 로고    scopus 로고
    • Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions
    • Lux A., Llacer H., Heussen F.M., and Joussen A.M. Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br J Ophthalmol 91 (2007) 1318-1322
    • (2007) Br J Ophthalmol , vol.91 , pp. 1318-1322
    • Lux, A.1    Llacer, H.2    Heussen, F.M.3    Joussen, A.M.4
  • 3
    • 38549096228 scopus 로고    scopus 로고
    • Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration
    • Joeres S., Kaplowitz K., Brubaker J.W., et al. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration. Ophthalmology 115 (2008) 347-354
    • (2008) Ophthalmology , vol.115 , pp. 347-354
    • Joeres, S.1    Kaplowitz, K.2    Brubaker, J.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.